Bo Ahrén
61 – 70 of 393
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Incretin hormone receptors are required for normal beta cell development and function in female mice
(
- Contribution to journal › Article
-
Mark
Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis.
(
- Contribution to journal › Article
-
Mark
Mixed meal diminishes glucose excursion compared to glucose by several adaptive mechanisms in man.
(
- Contribution to journal › Article
-
Mark
Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.
2016) In Diabetologia(
- Contribution to journal › Article
- 2015
-
Mark
Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin.
(
- Contribution to journal › Article
-
Mark
Glucagon-early breakthroughs and recent discoveries.
(
- Contribution to journal › Scientific review
-
Mark
Incretin and islet hormone responses to meals of increasing size in healthy subjects.
(
- Contribution to journal › Article
-
Mark
Creative use of novel glucose-lowering drugs for type 2 diabetes: where will we head in the next 50 years?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Incretin Effect after Oral Amino Acid Ingestion in Humans.
(
- Contribution to journal › Article
-
Mark
DPP-4 inhibition contributes to the prevention of hypoglycaemia through a GIP-glucagon counterregulatory axis in mice.
(
- Contribution to journal › Article